The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CTC enumeration and characterization as a pharmacodynamic marker in the phase I clinical study of APX3330, an APE1/Ref-1 inhibitor, in patients with advanced solid tumors.
 
Lincy Chu
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Amanda K. L. Anderson
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Mark Andrew Landers
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Yipeng Wang
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Mark R. Kelley
Leadership - Apexian Pharmaceuticals
Stock and Other Ownership Interests - Apexian Pharmaceuticals
Consulting or Advisory Role - Apexian Pharmaceuticals
Patents, Royalties, Other Intellectual Property - I have a number of antibodies that have been licensed from Indiana University School of Medicine that are sold by various companies. The royalties come back to the school and I share in some of them.
 
Richard Adam Messmann
Employment - Endocyte
Leadership - Endocyte
Stock and Other Ownership Interests - Apexian Pharmaceuticals; Endocyte
Patents, Royalties, Other Intellectual Property - I old patents with both Endocyte Inc., and Apexian Pharmaceuticals, Inc. In both cases, all rights and royalties have been transferred to the respective companies.
Travel, Accommodations, Expenses - Apexian Pharmaceuticals; Endocyte